Clinical Trial Update: A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial comparing GZR4 Injection with insulin degludec in adults with Type 2 diabetes assessed efficacy and safety; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR4 Injection (GZR4)
• insulin degludec (insulin degludec)

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED